Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

BSX

Boston Scientific Corp

Sep 12 • 04:00PM ET

102.71

-1.63 -1.56 %

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT JNJ SYK ZBH ISRG BDX EW HOLX XRAY

| Held by: VTI VOO SPY IVV VUG XLV VHT IHI IVW IWD

Index	S&P 500	P/E	61.13	EPS (ttm)	1.68	Insider Own	0.62%	Shs Outstand	1.48B	Perf Week	-4.21%
Market Cap	152.19B	Forward P/E	30.19	EPS next Y	3.40	Insider Trans	-7.68%	Shs Float	1.47B	Perf Month	0.20%
Enterprise Value	163.81B	PEG	4.02	EPS next Q	0.72	Inst Own	92.71%	Short Float	1.29%	Perf Quarter	4.21%
Income	2.51B	P/S	8.23	EPS this Y	18.83%	Inst Trans	0.73%	Short Ratio	2.67	Perf Half Y	7.70%
Sales	18.49B	P/B	6.78	EPS next Y	14.06%	ROA	6.37%	Short Interest	18.99M	Perf YTD	14.99%
Book/sh	15.14	P/C	236.69	EPS next 5Y	15.20%	ROE	11.71%	52W High	109.50 -6.20%	Perf Year	23.66%
Cash/sh	0.43	P/FCF	43.67	EPS past 3/5Y	21.99% -17.84%	ROIC	7.38%	52W Low	80.64 27.37%	Perf 3Y	147.67%
Dividend Est.	-	EV/EBITDA	37.25	Sales past 3/5Y	12.10% 9.30%	Gross Margin	61.90%	Volatility	2.30% 1.76%	Perf 5Y	147.61%
Dividend TTM	-	EV/Sales	8.86	EPS Y/Y TTM	36.19%	Oper. Margin	16.66%	ATR (14)	1.99	Perf 10Y	521.36%
Dividend Ex-Date	-	Quick Ratio	0.82	Sales Y/Y TTM	21.45%	Profit Margin	13.55%	RSI (14)	38.80	Recom	1.28
Dividend Gr. 3/5Y	- -	Current Ratio	1.37	EPS Q/Q	144.43%	SMA20	-2.79%	Beta	0.63	Target Price	125.70
Payout	0.00%	Debt/Eq	0.54	Sales Q/Q	22.84%	SMA50	-2.04%	Rel Volume	1.48	Prev Close	104.34
Employees	53000	LT Debt/Eq	0.52	Earnings	Jul 23 BMO	SMA200	2.16%	Avg Volume	7.10M	Price	102.71
IPO	May 19, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.38% 3.43%	Trades		Volume	10,541,563	Change	-1.56%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-08-25	Upgrade	Oppenheimer	Perform → Outperform	$125
Jun-16-25	Initiated	Leerink Partners	Outperform	$118
Apr-16-25	Upgrade	Needham	Hold → Buy	$113
Jan-10-25	Upgrade	Deutsche Bank	Hold → Buy	$108
Oct-18-24	Downgrade	Needham	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$90
Feb-01-24	Upgrade	Mizuho	Neutral → Buy	$65 → $80
Jul-19-23	Initiated	Robert W. Baird	Outperform	$59
Jun-30-23	Initiated	CL King	Buy	$64
May-30-23	Resumed	Morgan Stanley	Overweight	$58
Mar-29-23	Initiated	UBS	Buy	$57
Dec-22-22	Initiated	Mizuho	Neutral	$52
Dec-20-22	Resumed	Citigroup	Buy	$54
Oct-18-22	Initiated	Barclays	Overweight	$49
Oct-12-22	Initiated	Jefferies	Buy	$50
Jul-06-22	Initiated	Wolfe Research	Outperform	$43
May-27-22	Upgrade	Needham	Hold → Buy	$48
Apr-13-22	Resumed	Truist	Buy	$52
Mar-02-22	Resumed	BofA Securities	Buy	$55
Dec-10-21	Initiated	RBC Capital Mkts	Outperform	$51

Show Previous Ratings

Today 07:17AM	Puzzling: Farapulse trial investigator on the devices use beyond recommendations (Medical Device Network)
Sep-11-25 05:18AM	Elutia to divest bioenvelopes business to Boston Scientific for $88m (Medical Device Network)
Sep-10-25 06:00PM	Boston Scientific, U.S. Physical Therapy, 10x Genomics, GE HealthCare, and Integer Holdings Shares Are Falling, What You Need To Know (StockStory)
06:00PM	Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors (Zacks)
12:35PM	Reasons to Retain Avanos Medical Stock in Your Portfolio Now (Zacks)
06:20AM	Loading…
06:20AM	Boston Scientific inks $88M Elutia deal to challenge Medtronic (MedTech Dive)
Sep-09-25 01:25PM	Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System (Zacks)
Sep-08-25 12:50PM	Oppenheimer sees stronger growth at Boston Scientific (Investing.com)
12:36PM	Cardinal Health Expands At-Home Solutions With New Texas Facility (Zacks)
09:49AM	Alphabet downgraded, Boeing upgraded: Wall Street's top analyst calls (The Fly)
08:07AM	GEHC Stock Gains Following Launch of Revolution Vibe CT Imaging System (Zacks)
Sep-05-25 12:30PM	PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq (Zacks)
08:06AM	Here's Why You Should Hold Cencora Stock in Your Portfolio Now (Zacks)
Sep-04-25 02:20PM	Healthcare Stocks Are Just Starting Their Resurgence. Hold On to Them. (Barrons.com)
11:40AM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
06:00AM	Loading…
06:00AM	Kardium receives FDA OK for pulsed field ablation system (MedTech Dive)
Sep-03-25 01:23PM	HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y (Zacks)
09:30AM	Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
08:50AM	STXS Launches First U.S. Robotic HD Mapping With MAGiC Sweep (Zacks)
04:35AM	Is Boston Scientific Stock Outperforming the S&P 500? (Barchart)
Sep-02-25 06:00PM	Boston Scientific (BSX) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
01:32PM	IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection (Zacks)
08:00AM	Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results (PR Newswire)
Sep-01-25 12:53PM	GEHC Launches AI-Powered Vivid Pioneer Cardiac Ultrasound System (Zacks)
Aug-29-25 12:24PM	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
09:47AM	Here's Why You Should Add CLOV Stock to Your Portfolio Now (Zacks)
09:47AM	COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down (Zacks)
09:40AM	Are Medical Stocks Lagging Boston Scientific (BSX) This Year? (Zacks)
08:06AM	The Role of M&A in Hologic's Growth Story: Are More Deals in Sight? (Zacks)
07:00AM	Is your AI bet too big? How to balance with other growth themes (Yahoo Finance Video)
10:24AM	Loading…
Aug-28-25 10:24AM	VEEV Q2 Earnings & Revenues Beat Estimates, Margin Rises, Stock Up (Zacks)
08:50AM	DGX Stock Gains Following a New Joint Venture With Corewell Health (Zacks)
08:49AM	Should You Continue to Hold Thermo Fisher Stock in Your Portfolio? (Zacks)
08:14AM	PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down (Zacks)
08:11AM	Should You Add Zimmer Biomet Stock to Your Portfolio Now? (Zacks)
Aug-27-25 12:25PM	PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment (Zacks)
08:40AM	What's Driving Abbott's Gross Margin Growth Amid Macro Issues (Zacks)
08:31AM	Should You Add IDEXX Stock to Your Portfolio Right Now? (Zacks)
08:29AM	Here's Why You Should Retain CONMED Stock in Your Portfolio for Now (Zacks)
Aug-26-25 08:25AM	Is it the Right Time to Hold Labcorp Stock in Your Portfolio? (Zacks)
Aug-25-25 06:33PM	3 Biotech Catalysts Present Major Opportunity (MarketBeat)
02:26PM	8 Growth Stocks to Buy That Aren't Technology. What Makes Them Worth It. (Barrons.com)
12:52PM	Natera Shares Rise on the Launch of AI Platform for Precision Oncology (Zacks)
08:47AM	IDEXX Gains 56.2% in a Year: What's Driving the Rally? (Zacks)
08:31AM	HOLX vs. BSX: Which Healthcare Stock Has More Room to Grow? (Zacks)
Aug-24-25 11:27PM	Boston Scientific recalls carotid stents over manufacturing defect (MedTech Dive)
Aug-23-25 08:02AM	Uber Leads 5 Stocks Near Buy Points As Market Rebounds (Investor's Business Daily)
Aug-22-25 04:27PM	Stock Market Week Ahead: Nvidia, Dollar Stores And Canada's Big 5 Banks (Investor's Business Daily)
01:30PM	BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care (Zacks)
11:30AM	Boston Scientific (BSX) Down 0.9% Since Last Earnings Report: Can It Rebound? (Zacks)
09:55AM	Should Boston Scientific Stock Be in Your Portfolio Right Now? (Zacks)
09:55AM	Insulet Gains 77.2% in a Year: What's Driving the Rally? (Zacks)
08:02AM	4 Medical Devices Behemoths to Buy Amid Extensive AI Applications (Zacks)
Aug-21-25 01:33PM	Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market (Zacks)
01:30PM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
11:15AM	Mizuho Raises Boston Scientific (BSX) Price Target as Robotics and Devices Drive Growth (Insider Monkey)
10:14AM	Should Quest Diagnostics Stock Be in Your Portfolio Right Now? (Zacks)
10:12AM	Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges (Zacks)
09:50AM	Teleflex Stock Gains Following Barrigel's Launch in Japan (Zacks)
Aug-20-25 01:24PM	Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring (Zacks)
01:11PM	IBD Stock Of The Day Boston Scientific Breaks Out - Here's Why (Investor's Business Daily)
01:05PM	IBD Stock Of The Day Boston Scientific Flashing Early Buy Signal (Investor's Business Daily)
11:40AM	PAHC vs. BSX: Which Stock Is the Better Value Option? (Zacks)
11:20AM	GEHC Positioned for Growth With AI, Global Expansion and Margins (Zacks)
08:54AM	PAHC Stock Up 76.4% in a Year: What's Driving the Rally? (Zacks)
Aug-19-25 10:13AM	NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment (Zacks)
09:48AM	MDT Stock Falls Despite Q1 Earnings & Revenue Beat, FY26 EPS View Up (Zacks)
08:50AM	Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds (Zacks)
08:05AM	Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up (Zacks)
Aug-18-25 09:30AM	Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet (Zacks)
Aug-15-25 09:43PM	Jefferies Reiterates a Buy Rating on Boston Scientific Corporation (BSX), Sets a $130 PT (Insider Monkey)
02:51AM	FDA Monitors Safety Issue with Boston Scientific Defibrillator Leads (Insider Monkey)
12:03AM	2 Reasons to Like BSX (and 1 Not So Much) (StockStory)
Aug-14-25 04:05PM	Elutia Delivers Robust Growth on the Strength of EluPro Market Adoption (GlobeNewswire)
11:17AM	Accuray Stock Down as Q4 Earnings Miss Estimates, Revenues Down Y/Y (Zacks)
11:05AM	Reasons to Hold HealthEquity Stock in Your Portfolio for Now (Zacks)
06:32AM	Boston Scientific Watchman device procedure risk (Medical Device Network)
Aug-13-25 12:58PM	RGTI Stock Down Despite Q2 Earnings Top Estimates, Revenues Decline Y/Y (Zacks)
09:40AM	Are Medical Stocks Lagging Boston Scientific (BSX) This Year? (Zacks)
08:37AM	MDT Stock Trades Cheaper Than Peers Ahead of Q1 Earnings: Time to Buy? (Zacks)
08:22AM	Globus Medical Stock Up on Q2 Earnings & Revenue Beat, Margins Expand (Zacks)
Aug-12-25 04:27PM	Boston Scientific Stock Hits A Record High, Consolidates. Prepping For Another Run? (Investor's Business Daily)
04:25PM	Boston Scientific At The Starting Line Again After Its Stock Hits A Record High, Consolidates. (Investor's Business Daily)
01:02PM	SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts (Zacks)
12:45PM	3 Reasons Growth Investors Will Love Boston Scientific (BSX) (Zacks)
11:41AM	Reasons to Add Veeva Systems Stock to Your Portfolio for Now (Zacks)
10:37AM	CAH Q4 Earnings Beat Estimates, '26 EPS View Up, Stock Falls (Zacks)
08:27AM	EXAS Stock Dips Despite Q2 Earnings & Revenue Beat, '25 Sales View Up (Zacks)
08:25AM	Insulet Q2 Earnings & Revenues Beat Estimates, Stock Up, Margins Rise (Zacks)
08:14AM	J&J's MedTech Unit Sales Improve in Q2: Will the Upside Continue? (Zacks)
04:42AM	US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 \| Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD (GlobeNewswire)
Aug-11-25 10:02AM	SetPoint Medical secures $140M to fund neuromodulation for arthritis (MedTech Dive)
09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
08:27AM	Bruker's Q2 Earnings Miss Estimates, Stock Tumbles, Margins Contract (Zacks)
Aug-08-25 04:38PM	Top Stock Reports for JPMorgan Chase, Chevron & Shopify (Zacks)
01:17PM	The Stock Market Gains Despite Noisy Week. Call It Complacency-or the Right Thing to Do. (Barrons.com)
12:24PM	Boston Scientific Reports 16 Deaths Linked To Defibrillator Lead Issue (Benzinga)
12:11PM	Inogen Stock Gains Following Q2 Earnings Beat, Revenues Up Y/Y (Zacks)
12:07PM	PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises (Zacks)
11:51AM	DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down (Zacks)

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Sep 03 04:17 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Sale	105.43	50,000	5,271,416	178,342	Sep 03 04:17 PM
JOSEPH M FITZGERALD	Officer	Sep 02 '25	Proposed Sale	105.43	50,000	5,271,415		Sep 02 04:08 PM
Monson Jonathan	EVP and CFO	Aug 02 '25	Option Exercise	0.00	1,090	0	35,817	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Sale	104.63	50,000	5,231,670	178,342	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Option Exercise	24.81	17,313	429,493	40,913	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Sale	104.63	17,313	1,811,520	23,600	Aug 04 05:43 PM
ARTHUR C BUTCHER	Officer	Aug 01 '25	Proposed Sale	104.63	17,313	1,811,519		Aug 01 04:03 PM
JOSEPH M FITZGERALD	Officer	Aug 01 '25	Proposed Sale	104.63	50,000	5,231,665		Aug 01 04:02 PM
FUJIMORI YOSHIAKI	Director	Jul 29 '25	Sale	106.99	2,901	310,378	2,081	Jul 30 04:06 PM
YOSHIAKI FUJIMORI	Director	Jul 29 '25	Proposed Sale	106.99	2,901	310,378		Jul 29 07:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Sale	106.03	4,000	424,120	18,479	Jul 28 04:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Proposed Sale	107.46	4,000	429,840		Jul 25 01:02 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Jul 02 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Sale	106.97	50,000	5,348,315	178,342	Jul 02 04:09 PM
Brown Vance R	SVP, GC and Corp. Secretary	Jul 01 '25	Option Exercise	0.00	4,036	0	35,403	Jul 02 04:09 PM
JOSEPH M FITZGERALD	Officer	Jul 01 '25	Proposed Sale	106.97	50,000	5,348,310		Jul 01 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Option Exercise	26.15	56,372	1,474,128	234,714	Jun 04 07:44 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Sale	102.88	56,372	5,799,630	178,342	Jun 04 07:44 PM
JOSEPH M FITZGERALD	Officer	Jun 04 '25	Proposed Sale	102.88	56,372	5,799,625		Jun 04 04:02 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Option Exercise	20.67	105,619	2,183,161	1,641,325	Jun 03 04:47 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Sale	103.69	164,443	17,051,136	1,476,882	Jun 03 04:47 PM
MICHAEL F MAHONEY	Officer	Jun 02 '25	Proposed Sale	103.69	164,443	17,051,132		Jun 02 04:05 PM
LUDWIG EDWARD J	Director	May 29 '25	Sale	104.59	4,000	418,368	22,479	May 30 04:08 PM
LUDWIG EDWARD J	Director	May 29 '25	Proposed Sale	104.54	4,000	418,160		May 29 03:39 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 21 '25	Sale	106.42	4,826	513,583	31,367	May 22 04:08 PM
VANCE BROWN	Officer	May 21 '25	Proposed Sale	106.42	4,826	513,583		May 21 04:09 PM
Sorenson John Bradley	EVP, Global Operations	May 02 '25	Option Exercise	0.00	4,204	0	25,195	May 06 04:37 PM
Sorenson John Bradley	EVP, Global Operations	May 05 '25	Sale	104.54	4,572	477,957	18,705	May 06 04:37 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 02 '25	Option Exercise	0.00	2,102	0	24,337	May 06 04:36 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Option Exercise	20.67	105,619	2,183,161	1,700,149	May 05 05:16 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Sale	102.48	164,443	16,851,974	1,535,706	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Option Exercise	24.81	17,314	429,515	39,549	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Sale	102.06	17,314	1,766,982	22,235	May 05 05:16 PM
JOHN B SORENSON	Officer	May 05 '25	Proposed Sale	104.54	4,572	477,957		May 05 04:04 PM
MICHAEL F MAHONEY	Officer	May 01 '25	Proposed Sale	102.48	164,443	16,851,966		May 01 04:05 PM
ARTHUR C BUTCHER	Officer	May 01 '25	Proposed Sale	102.06	17,314	1,766,981		May 01 04:01 PM
Brown Vance R	SVP, GC and Corp. Secretary	Apr 21 '25	Sale	95.09	4,826	458,904	36,193	Apr 22 04:09 PM
VANCE BROWN	Officer	Apr 21 '25	Proposed Sale	95.09	4,826	458,904		Apr 21 04:01 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Option Exercise	20.67	105,618	2,183,144	1,758,972	Apr 02 04:12 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Sale	100.01	164,442	16,445,072	1,594,530	Apr 02 04:12 PM
MICHAEL F MAHONEY	Officer	Apr 01 '25	Proposed Sale	100.01	164,442	16,445,068		Apr 01 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	Mar 21 '25	Sale	100.85	4,826	486,702	41,019	Mar 24 04:26 PM
VANCE BROWN	Officer	Mar 21 '25	Proposed Sale	100.85	4,826	486,702		Mar 21 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Option Exercise	37.50	5,949	223,088	8,063	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Sale	104.97	7,149	750,465	914	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 04 '25	Sale	104.63	482	50,432	432	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Option Exercise	42.16	7,218	304,311	11,519	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 01 '25	Option Exercise	0.00	837	0	2,469	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Sale	101.13	9,887	999,872	1,632	Mar 03 04:11 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 24 '25	Sale	104.25	4,675	487,369	28,454	Feb 25 04:41 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 25 '25	Sale	104.00	2,688	279,552	25,766	Feb 25 04:41 PM
JEFFREY B MIRVISS	Officer	Feb 25 '25	Proposed Sale	104.00	2,688	279,552		Feb 25 04:02 PM
Zane Ellen M	Director	Feb 24 '25	Sale	104.23	13,586	1,416,134	34,944	Feb 24 04:08 PM
JEFFREY B MIRVISS	Officer	Feb 24 '25	Proposed Sale	104.25	4,675	487,369		Feb 24 04:01 PM
Zane Ellen M	Director	Feb 24 '25	Proposed Sale	104.23	13,586	1,416,088		Feb 24 11:30 AM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 21 '25	Sale	104.64	4,826	504,993	45,845	Feb 21 04:15 PM
VANCE BROWN	Officer	Feb 21 '25	Proposed Sale	104.64	4,826	504,993		Feb 21 04:03 PM
Sorenson John Bradley	EVP, Global Operations	Feb 19 '25	Sale	105.19	3,303	347,443	20,991	Feb 19 04:23 PM
Sorenson John Bradley	EVP, Global Operations	Feb 18 '25	Sale	104.41	2,657	277,417	24,294	Feb 19 04:23 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 19 '25	Sale	105.35	1,510	159,078	33,129	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Option Exercise	25.61	60,523	1,550,275	293,141	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Sale	105.24	67,333	7,086,111	225,808	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 18 '25	Sale	104.57	17,530	1,833,184	232,618	Feb 19 04:23 PM
DANIEL BRENNAN	Officer	Feb 19 '25	Proposed Sale	105.24	67,333	7,086,109		Feb 19 04:05 PM
JEFFREY B MIRVISS	Officer	Feb 19 '25	Proposed Sale	105.35	1,510	159,078		Feb 19 04:01 PM
JOHN B SORENSON	Officer	Feb 19 '25	Proposed Sale	105.19	3,303	347,443		Feb 19 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 14 '25	Option Exercise	0.00	661	0	3,867	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 16 '25	Option Exercise	0.00	636	0	4,188	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 17 '25	Option Exercise	0.00	667	0	4,584	Feb 18 05:53 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Option Exercise	0.00	2,115	0	27,609	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 17 '25	Option Exercise	0.00	1,500	0	27,635	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 16 '25	Option Exercise	0.00	1,273	0	26,716	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Sale	106.31	1,201	127,678	25,443	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	100	0	1,767	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	1,000	0	15,071	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	85	0	1,697	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	990	0	14,362	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	106	0	1,650	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	1,123	0	13,702	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17 '25	Option Exercise	0.00	3,334	0	36,160	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16 '25	Option Exercise	0.00	2,970	0	34,181	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 14 '25	Option Exercise	0.00	2,776	0	32,477	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 17 '25	Option Exercise	0.00	18,334	0	1,662,219	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 16 '25	Option Exercise	0.00	16,265	0	1,651,750	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 14 '25	Option Exercise	0.00	16,524	0	1,643,475	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 17 '25	Option Exercise	0.00	4,167	0	183,439	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 16 '25	Option Exercise	0.00	3,960	0	181,078	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 14 '25	Option Exercise	0.00	4,362	0	179,108	Feb 18 05:52 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 17 '25	Option Exercise	0.00	2,834	0	23,550	Feb 18 05:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 16 '25	Option Exercise	0.00	2,546	0	21,947	Feb 18 05:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 14 '25	Option Exercise	0.00	3,172	0	20,935	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 17 '25	Option Exercise	0.00	1,000	0	51,155	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 16 '25	Option Exercise	0.00	1,839	0	51,045	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 14 '25	Option Exercise	0.00	1,850	0	50,101	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 17 '25	Option Exercise	0.00	4,584	0	252,365	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 16 '25	Option Exercise	0.00	4,243	0	249,833	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 14 '25	Option Exercise	0.00	4,362	0	247,700	Feb 18 05:50 PM
JOHN B SORENSON	Officer	Feb 18 '25	Proposed Sale	104.41	2,657	277,417		Feb 18 04:09 PM

Peers: ABT BDX MDT QGEN ILMN BIO DGX A RMD

| Held by: VTI VOO VB VBR SPY IVV RSP XLV IHI COWZ

Index	S&P 500	P/E	26.74	EPS (ttm)	2.41	Insider Own	0.88%	Shs Outstand	222.22M	Perf Week	-3.46%
Market Cap	14.33B	Forward P/E	14.28	EPS next Y	4.51	Insider Trans	0.28%	Shs Float	220.46M	Perf Month	-6.57%
Enterprise Value	14.98B	PEG	3.92	EPS next Q	1.10	Inst Own	100.84%	Short Float	1.42%	Perf Quarter	-1.18%
Income	557.10M	P/S	3.55	EPS this Y	3.98%	Inst Trans	-1.39%	Short Ratio	1.65	Perf Half Y	6.18%
Sales	4.04B	P/B	2.96	EPS next Y	6.36%	ROA	6.30%	Short Interest	3.12M	Perf YTD	-10.60%
Book/sh	21.79	P/C	7.63	EPS next 5Y	6.83%	ROE	11.38%	52W High	84.39 -23.63%	Perf Year	-21.36%
Cash/sh	8.45	P/FCF	15.38	EPS past 3/5Y	-22.74% -	ROIC	7.57%	52W Low	51.90 24.18%	Perf 3Y	-4.80%
Dividend Est.	-	EV/EBITDA	12.01	Sales past 3/5Y	-10.56% 3.66%	Gross Margin	55.93%	Volatility	1.98% 1.80%	Perf 5Y	10.66%
Dividend TTM	-	EV/Sales	3.71	EPS Y/Y TTM	-17.73%	Oper. Margin	23.58%	ATR (14)	1.25	Perf 10Y	67.71%
Dividend Ex-Date	-	Quick Ratio	2.81	Sales Y/Y TTM	1.28%	Profit Margin	13.79%	RSI (14)	38.25	Recom	2.30
Dividend Gr. 3/5Y	- -	Current Ratio	3.55	EPS Q/Q	5.09%	SMA20	-3.58%	Beta	0.63	Target Price	74.00
Payout	0.00%	Debt/Eq	0.52	Sales Q/Q	1.23%	SMA50	-2.91%	Rel Volume	0.53	Prev Close	66.38
Employees	7063	LT Debt/Eq	0.52	Earnings	Jul 30 AMC	SMA200	-1.55%	Avg Volume	1.90M	Price	64.45
IPO	Mar 01, 1990	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.52% 1.32%	Trades		Volume	1,005,450	Change	-2.91%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-18-25	Upgrade	Argus	Hold → Buy	$80
Aug-06-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$87
Jul-09-25	Upgrade	Citigroup	Neutral → Buy	$80
May-27-25	Reiterated	Needham	Hold
Mar-03-25	Downgrade	Argus	Buy → Hold
Feb-06-25	Downgrade	Leerink Partners	Outperform → Market Perform	$80 → $75
Feb-03-25	Downgrade	Needham	Buy → Hold
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-10-24	Reiterated	Needham	Buy	$90
Dec-10-24	Initiated	Jefferies	Hold	$85
Oct-01-24	Downgrade	Citigroup	Buy → Neutral	$95 → $85
Jun-27-24	Initiated	Stephens	Overweight	$87
Apr-03-24	Upgrade	Citigroup	Neutral → Buy	$80 → $95
Jul-14-23	Upgrade	Needham	Hold → Buy	$95
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$75
Oct-13-22	Initiated	Mizuho	Buy	$75
Jul-20-22	Initiated	UBS	Neutral	$73
Jul-20-22	Downgrade	BofA Securities	Buy → Neutral	$81 → $75
Jul-18-22	Downgrade	BTIG Research	Buy → Neutral
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$75

Show Previous Ratings

Sep-11-25 07:50AM	Does Hologic (HOLX) Have a Compelling Valuation? (Insider Monkey)
Sep-10-25 05:45PM	Hologic (HOLX) Stock Sinks As Market Gains: What You Should Know (Zacks)
10:06AM	Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds (Zacks)
Sep-09-25 07:04AM	US hospital STI testing sales drop amid multifactorial causes (Medical Device Network)
Sep-08-25 04:32PM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
08:47AM	Loading…
Sep-04-25 08:47AM	Hologic's Panther Fusion Signals More Molecular Diagnostics Upside (Zacks)
Sep-03-25 04:02PM	Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference (Business Wire)
Aug-29-25 11:30AM	Hologic (HOLX) Down 0.3% Since Last Earnings Report: Can It Rebound? (Zacks)
08:06AM	The Role of M&A in Hologic's Growth Story: Are More Deals in Sight? (Zacks)
Aug-26-25 09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
Aug-25-25 08:31AM	HOLX vs. BSX: Which Healthcare Stock Has More Room to Grow? (Zacks)
Aug-21-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Aug-20-25 09:40AM	Here's Why Hologic (HOLX) is a Strong Value Stock (Zacks)
09:00AM	What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit? (Zacks)
Aug-15-25 09:00AM	Is Trending Stock Hologic, Inc. (HOLX) a Buy Now? (Zacks)
02:41AM	Loading…
Aug-14-25 02:41AM	What Are Wall Street Analysts' Target Price for Hologic Stock? (Barchart)
Aug-13-25 08:25AM	Hologic Eyes Organic Growth Rebound in 2026 on Breast Health Strength (Zacks)
Aug-12-25 11:55PM	Hologic's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory)
11:53PM	HOLX Q2 Deep Dive: Breast Health Turnaround and New Product Launches Drive Momentum (StockStory)
04:49AM	STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories (GlobeNewswire)
Aug-11-25 07:30AM	[Latest] Global Digital Mammography Market Size/Share Worth USD 5.32 Billion by 2034 at a 11.26% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
Aug-08-25 08:43AM	Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It? (Zacks)
Aug-06-25 07:38AM	Should You Buy, Sell or Hold Hologic Stock Post Q3 Earnings? (Zacks)
Aug-05-25 09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
09:04AM	Tempus AI Targets Breast Cancer With Expanded Next - AI Platform (Zacks)
Aug-04-25 09:40AM	Why Hologic (HOLX) is a Top Value Stock for the Long-Term (Zacks)
09:15AM	Interpreting Hologic (HOLX) International Revenue Trends (Zacks)
09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Aug-01-25 08:50AM	Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings (Zacks)
Jul-31-25 07:59AM	Hologic Stock Falls Despite Q3 Earnings and Revenue Beat, Margins Down (Zacks)
05:10AM	Loading…
05:10AM	Analyst Report: Hologic, Inc. (Morningstar Research)
03:31AM	Hologic Inc (HOLX) Q3 2025 Earnings Call Highlights: Surpassing Expectations Amidst Challenges (GuruFocus.com)
Jul-30-25 05:30PM	Compared to Estimates, Hologic (HOLX) Q3 Earnings: A Look at Key Metrics (Zacks)
05:10PM	Hologic (HOLX) Q3 Earnings and Revenues Beat Estimates (Zacks)
04:08PM	Hologic: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:06PM	Hologic's (NASDAQ:HOLX) Q2 Sales Beat Estimates, Stock Soars (StockStory)
04:01PM	Hologic Announces Financial Results for Third Quarter of Fiscal 2025 (Business Wire)
Jul-29-25 08:05AM	Hologic Focuses on Breast Health Turnaround This Year: Can It Deliver? (Zacks)
04:02AM	Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche (GlobeNewswire)
Jul-28-25 11:18PM	Hologic (HOLX) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-25-25 09:22AM	Mammography Equipment Market Analysis and Forecast Report 2025: Hologic, Siemens, GE Lead Competitive Dynamics in Mammography Industry (GlobeNewswire)
09:15AM	Seeking Clues to Hologic (HOLX) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
08:38AM	HOLX vs. EXAS: Which Cancer Diagnostics Stock Should You Retain Now? (Zacks)
Jul-24-25 09:06AM	Hologic's International Momentum Takes Shape: Will Execution Pay Off? (Zacks)
Jul-23-25 04:30AM	[Latest] Global Inferior Vena Cava IVC Filter Market Size/Share Worth USD 2,094.10 Million by 2034 at a 8.88% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT) (GlobeNewswire)
Jul-22-25 05:45PM	Hologic (HOLX) Laps the Stock Market: Here's Why (Zacks)
08:32AM	Is Hologic Stock a Risky Investment Ahead of Its Q3 Earnings Report? (Zacks)
Jul-16-25 08:55AM	Hologic Rides on AI-Powered Breast Health Innovations: What's Next? (Zacks)
Jul-15-25 05:45PM	Why Hologic (HOLX) Dipped More Than Broader Market Today (Zacks)
12:08PM	What to Expect From Hologic's Q3 2025 Earnings Report (Barchart)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jul-14-25 04:11PM	Analyst Report: Hologic, Inc. (Morningstar Research)
Jul-11-25 04:07AM	Chlamydia Market Analysis and Forecast, 2025-2035 Featuring ActivBiotics, Bausch Health, Allergan, WCG Clinical, Hologic, Evofem, CRMI, Meridian Bioscience, Pfizer (GlobeNewswire)
Jul-10-25 08:25AM	Hologic's GYN Surgical Dominance: What's Powering the Road Ahead? (Zacks)
Jul-09-25 05:45PM	Hologic (HOLX) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
Jul-08-25 08:31AM	Is Hologic Stock's Low Valuation an Opportunity or a Value Trap? (Zacks)
Jul-04-25 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jul-02-25 04:05PM	Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025 (Business Wire)
09:35AM	Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern (Zacks)
Jun-26-25 05:45PM	Hologic (HOLX) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
04:08AM	5 Revealing Analyst Questions From Hologic's Q1 Earnings Call (StockStory)
Jun-25-25 09:13AM	How Hologic Leverages Its Financial Firepower to Drive Long-Term Value (Zacks)
Jun-23-25 09:32AM	HOLX vs. COO: Which GYN Surgical Stock Is the Better Investment Now? (Zacks)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jun-20-25 06:41AM	How Is Hologics Stock Performance Compared to Other Health Care Equipment Stocks? (Barchart)
Jun-17-25 05:45PM	Hologic (HOLX) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
Jun-16-25 08:30AM	Hologic's Margin Stability Amid Tariffs: What's Behind the Confidence? (Zacks)
Jun-11-25 08:29AM	Can Hologic Lean on Its Strengths in a Tough Macroeconomic Climate? (Zacks)
Jun-10-25 08:04PM	Analyst Report: Hologic, Inc. (Morningstar Research)
09:00AM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
Jun-09-25 08:42AM	Hologic Climbs 13% in a Month: How Should You Play the Stock? (Zacks)
Jun-04-25 08:41AM	Hologic Navigates Breast Health Slump: Is the Growth Thesis Intact? (Zacks)
May-30-25 09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
May-28-25 05:16PM	S&P 500 Gains and Losses Today: FICO Shares Regain Ground After Recent Slump (Investopedia)
04:29AM	Why Hologic, Inc. (HOLX) Went Up On Tuesday (Insider Monkey)
May-27-25 11:35PM	Q1 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks (StockStory) +14.54%
05:22PM	S&P 500 Gains and Losses Today: Index Rises After Trump Extends EU Tariff Deadline (Investopedia)
04:07PM	Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. (Barrons.com)
02:04PM	Why Is Hologic (HOLX) Stock Rocketing Higher Today (StockStory)
08:24AM	HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick? (Zacks)
May-22-25 05:05PM	Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index Test in Helping to Deliver More Personalized Care to Patients (Business Wire)
May-21-25 12:01AM	3 Reasons to Sell HOLX and 1 Stock to Buy Instead (StockStory)
May-19-25 09:00AM	Is Trending Stock Hologic, Inc. (HOLX) a Buy Now? (Zacks)
May-15-25 04:46PM	HOLX Q1 Earnings Call: Tariffs, Market Headwinds, and Portfolio Diversification Shape 2025 Outlook (StockStory)
May-13-25 04:10PM	Hologic to Webcast Presentations at Upcoming Investor Conferences (Business Wire)
09:16AM	Understanding Hologic (HOLX) Reliance on International Revenue (Zacks)
May-12-25 08:44AM	Tariffs Dim Hologic's 2025 Expectations: Time to Reassess the Stock? (Zacks)
May-07-25 12:16PM	S&P 500's five most overbought and oversold stocks (Seeking Alpha)
May-06-25 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
12:32AM	1 of Wall Street's Favorite Stock with Impressive Fundamentals and 2 to Think Twice About (StockStory)
May-02-25 02:25PM	Analyst Report: Hologic, Inc. (Morningstar Research) -5.45%
11:57AM	Top Stock Movers Now: Dexcom, Berkshire Hathaway, Nvidia, and More (Investopedia)
10:11AM	Q2 2025 Hologic Inc Earnings Call (Thomson Reuters StreetEvents)
07:25AM	Hologic Q2 Earnings & Revenues Top, '25 EPS View Lowered, Stock Down (Zacks)
03:15AM	Hologic Inc (HOLX) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth (GuruFocus.com)
May-01-25 08:24PM	Hologic, Inc. (HOLX) Q2 2025 Earnings Call Transcript (Seeking Alpha)
05:30PM	Hologic (HOLX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:10PM	Hologic (HOLX) Tops Q2 Earnings and Revenue Estimates (Zacks)
04:17PM	Hologic: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Hologic Announces Financial Results for Second Quarter of Fiscal 2025 (Business Wire)

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Madaus Martin D	Director	May 07 '25	Buy	55.24	5,445	300,760	5,445	May 09 04:39 PM
Mitchell Essex D	Chief Operating Officer	Dec 04 '24	Option Exercise	62.60	22,902	1,433,659	52,813	Dec 06 04:28 PM
Mitchell Essex D	Chief Operating Officer	Dec 04 '24	Sale	76.34	24,856	1,897,482	27,957	Dec 06 04:28 PM
Mitchell Essex D	Officer	Dec 04 '24	Proposed Sale	76.34	24,856	1,897,484		Dec 04 12:24 PM

BSX

Boston Scientific Corp

HOLX

Hologic, Inc

Upgrade your FINVIZ experience